Find uplifting stories about heroes, innovations, and solutions
7 results for "car t therapy"
Nine patients with aggressive cancers are responding to a groundbreaking cell therapy that works like an on-off switch, avoiding the exhaustion problem that has limited cancer treatments. The therapy showed zero serious side effects and actual tumor shrinkage in patients who had already tried four other treatments.
A breakthrough immune therapy is transforming multiple myeloma from a disease that always returned into one where patients can reach long-term remission. More than 36,000 Americans diagnosed this year now have access to treatments once considered impossible.
Chinese scientists created a simple add-on that makes failing cancer treatments work again, without expensive genetic engineering. Patients who relapsed after CAR T therapy could now get a second chance at survival.
Scientists discovered that a natural molecule produced during fasting dramatically improves CAR T cell therapy against cancer in mice. Human trials are already underway to test whether this affordable supplement could help patients beat cancers that normally resist treatment.
Scientists created super-sensitive immune cells that completely eliminated kidney, ovarian, and pancreatic tumors in mice by detecting cancer cells previous treatments missed. The breakthrough could work against nearly two dozen different solid cancers.
The FDA just granted breakthrough status to a promising new CAR T-cell therapy designed to fight aggressive blood cancers. This designation could speed up access to a treatment that harnesses the immune system's power to target previously hard-to-treat malignancies.
Researchers at Mount Sinai created a therapy that doesn't attack cancer cells directly. Instead, it flips the immune cells protecting tumors, transforming defenders into destroyers.